Navigation Links
BioMS Medical Announces 2009 Year End Results
Date:3/16/2010

U.S. Food and Drug Administration (FDA) for Toraymyxin(TM), a treatment for severe sepsis. This approval permits Spectral to initiate its planned pivotal trial for Toraymyxin(TM) in the United States. - At the end of 2009, BioMS had reduced its headcount by approximately 50% to 15. Dirucotide Update ----------------- - On July 27, 2009, BioMS reported that the results of the MAESTRO-01 pivotal trial for dirucotide, its drug candidate for the treatment of multiple sclerosis, did not meet its efficacy endpoints. BioMS discontinued all ongoing clinical trials with dirucotide, and announced that it did not intend to pursue further late-stage trials. The licensing and development agreement between BioMS and Eli Lilly for dirucotide was terminated, with all commercial rights returning to BioMS.

Financial Results

The consolidated net income of the Corporation for the year ended December 31, 2009 was $2.9 million or $0.03 per share compared with a consolidated net loss of $(0.5) million or $(0.01) per share for the previous year. The consolidated net loss for the three months ended December 31, 2009 was $(7.2) million or $(0.08) per share compared with a consolidated net income of $0.3
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. BioMS Medical reports Spectral receives FDA approval to initiate pivotal trial and closes financing for $19.5 million
2. Spectral diagnostics Raises $14 million and enters into strategic collaboration with BioMS Medical to commercialize treatment for sepsis
3. BioMS Medical provides corporate update
4. BioMS Medical Announces Third Quarter 2009 Results
5. BioMS Medical announces second quarter 2009 results
6. BioMS Medical to present at the 2009 Symposium for the Canadian Society for Pharmaceutical Sciences
7. BioMS Medical to participate in panel session at Bio International Convention 2009
8. BioMS Medical Announces First quarter 2009 results
9. BioMS Medical to present at Alberta Economic Forum in Geneva
10. BioMS Medical to present at BioFinance 2009
11. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... SAN ANTONIO , 23 de julio de ... ADBI (ADBI o la Compañía) ha anunciado hoy ... Akron (ABIA o el Instituto), ... de ADBI, un dispositivo de terapia de señal ...   El Instituto, que tiene una ...
(Date:7/23/2014)... 23, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: ... sustainable chemicals, today announced that the underwriters of its ... to purchase an additional 420,000 shares of common ... per share, less underwriting discounts and commissions, in ... of 2,800,000 shares of common stock, bringing the ...
(Date:7/23/2014)... 23, 2014  Sofinnova Ventures, a Menlo ... closing of Sofinnova Venture Partners IX, L.P. at the ... the initial fund target of $425 million. ... companies. Consistent with recent funds, SVP IX will provide ... programs, along with select investments in earlier stage opportunities. ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 a2z Inc. ... ChirpE Mobile App, AACC Pathfinder, in its 2014 ... AACC’s annual meeting is planned for July 29-31, 2014 ... place to be to connect with global leaders in ... management, and other areas of breaking science in laboratory ...
Breaking Biology Technology:ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 3ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 4ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 5ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 6BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3Sofinnova Raises $500 Million Biotech Venture Fund 2AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 2AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 3
... sales of $84.0 million, a 7% increase over last year,s first , ... year-over-year , - Record pre-tax income of $15.4 million , - ... , first quarter , - New products ... , - Improvements in gross margin continue to demonstrate the strong ...
... 4 SenesTech, Inc. scientists, Drs. Loretta Mayer, ... attend the Third International Workshop on Fertility Control ... they presented SenesTech,s latest developments in humane animal ... organized by the governments of Australia, the United ...
... Micell Technologies announced today that David E. Kandzari, ... DES System" during the Cardiovascular Research Technologies (CRT) ... MiStent(TM), a Drug-Eluting Stent (DES) in pre-clinical studies, ... potential benefits of the drug during the healing ...
Cached Biology Technology:Martek Announces First Quarter 2009 Financial Results 2Martek Announces First Quarter 2009 Financial Results 3Martek Announces First Quarter 2009 Financial Results 4Martek Announces First Quarter 2009 Financial Results 5Martek Announces First Quarter 2009 Financial Results 6Martek Announces First Quarter 2009 Financial Results 7Martek Announces First Quarter 2009 Financial Results 8Martek Announces First Quarter 2009 Financial Results 9Martek Announces First Quarter 2009 Financial Results 10SenesTech Scientists Attend International Workshop on Fertility in New Zealand 2Micell Technologies' Rapid Absorption Polymer DES System to be Presented at CRT 2009 2
(Date:7/23/2014)... or neglected early in life are at risk ... In a new study, scientists have found that ... has implications for children,s long-term development. Previous studies ... and genetics interacted with that child,s experiences in ... In the new study, researchers were able to ...
(Date:7/23/2014)... Mass. Honey bees, especially the young, are highly ... work together to maintain temperatures within a narrow range. ... biologist at Tufts University,s School of Arts and Sciences, ... excess heat within a hive in process similar to ... blood vessels and skin. , "This study shows ...
(Date:7/23/2014)... super strength, but it also holds the promise of ... ability to convert sunlight into a clean, efficient alternative ... international group using spinach to study the proteins involved ... sun,s energy into carbohydrates used to power cellular processes. ... most efficient system ever built, capable of converting the ...
Breaking Biology News(10 mins):Stress tied to change in children's gene expression related to emotion regulation, physical health 2Stress tied to change in children's gene expression related to emotion regulation, physical health 3How honey bees stay cool 2Spinach could lead to alternative energy more powerful than Popeye 2
... the standard biological model of animal cell communication, UCSF ... the ability to transmit and receive biological signals by ... distance. The mechanism is similar to the way ... understanding that non-neuronal cells "basically spit out signaling proteins ...
... not the only organ in your body that can sense cigarette ... Louis and the University of Iowa have showed that your lungs ... nose, which are located in the membranes of nerve cells, the ... Instead of sending nerve impulses to your brain that allow it ...
... early indication of lay opinions on research with induced ... from skin or other tissues, a new study by ... ethical concerns, patients give the research "broad endorsement". ... of participating in iPSC research even if personal benefit ...
Cached Biology News:Animal cells can communicate by reaching out and touching, UCSF team discovers 2Animal cells can communicate by reaching out and touching, UCSF team discovers 3Odor receptors discovered in lungs 2Odor receptors discovered in lungs 3Odor receptors discovered in lungs 4Study finds patients give 'broad endorsement' to stem cell research 2Study finds patients give 'broad endorsement' to stem cell research 3
Rat monoclonal [HK5.3] to B7 RP1 (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 23308 SwissProtID: O75144...
... with the HECT protein, E6-AP ... Evidence suggests that this E2 ... degradation of non-""N-end rule"" protein ... -acetylated proteins as well as ...
NANS Immunogen: NANS (NP_061819, 260 a.a. ~ 360 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
ANTI-RAT ADHESION MARKERS, CDs, CYTOKINES, ETC Rat ICAM PE - Mouse IgG1...
Biology Products: